期刊文献+

长期血液透析和肾移植患者血清HDL-C和apoA-I水平 被引量:3

暂未订购
导出
摘要 本文对41例慢性肾衰血透患者和17例接受移植肾患者的血清脂蛋白和载脂蛋白水平进行了研究。结果表明,血透病人组HDL-C、HDL_2-C 和apoA-I 明显低子对照组,apoA-I/HDL-C 明显增加,尤其在伴有心血管并发症组更加明显。提示HDL-C 量和质的改变在动脉粥样硬化的进展中超重要作用。肾移植组HDL_3-C 和LDL-C 增加显著;HDL-C 和apoA-I 水平亦明显高于对照组和血透组,且二者呈正相关。但尚不能排除使用激素和/或环孢素影响的可能性。
出处 《江苏医药》 CAS CSCD 1990年第5期258-260,共3页 Jiangsu Medical Journal
  • 相关文献

同被引文献46

  • 1Yang, Yong-Jiu,Li, Li-Xin,He, Qiang,Fan, Hua,Jin, Zhong-Kui,Lang, Ren,Kou, Jian-Tao,Li, Peng,Xie, De-Hong,Chen, Da-Zhi.Sirolimus as primary immunosuppressant for calcineurin inhibitor-related renal insufficiency after liver transplantation[J].Hepatobiliary & Pancreatic Diseases International,2007,6(4):376-378. 被引量:5
  • 2医疗机构管理条例[J].中华人民共和国国务院公报,1994,0(3):83-89. 被引量:10
  • 3刘敏,季曙明,唐政,陈劲松,沙国柱,殷立平,陈惠萍,刘志红,黎磊石.环孢素A切换成他克莫司对慢性移植肾肾病患者血脂的影响[J].肾脏病与透析肾移植杂志,2005,14(1):23-27. 被引量:11
  • 4Womer KL, Vella JP, Sayegh MH. Chronic allograft dysfunction:mechanisms and new approaches to therapy. Seminars in Nephrology,2000,20(2): 126.
  • 5Dimeny E, Fellstrom B, Larsson E,et al. Hyperlipoproteinemia in renal transplant recipients: is there a linkage with chronic vascular rejection? Transplant Proc, 1993,25 (2): 2065.
  • 6Raine AE. Does antihypertensive therapy modify chronic allograft failure? Kidney Int(Suppl) , 1995,52: S107.
  • 7Vathsala A, Weinberg RB,Schoenberg L, et al. Lipid abnormalities in cyclosporine-prednisone-treated renal transplant recipients. Transplantation, 1989,48 ( 1 ) :37.
  • 8Starzl TE, Todo S, Fung J,et al. FK 506 for liver, kidney, and pancreas transplantation. Lancet, 1989,28,2 (8670): 1000.
  • 9Hamar P, Mǘller V, Kohnle M,et al. Metabolic factors have a major impact on outcome of renal kidney transplantation. Transplantation,1997,64(8) :1135.
  • 10Kasiske BL, Tortoriee KL, Heim-Duthoy KL,et al. The adverse impact of cyclosporin on serum lipids in renal transplant recipients. Am J Kidney Dis, 1991,17 ( 6 ) :700.

引证文献3

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部